Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C MacKinnon

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
The American Journal of Pathology|January 19, 2008
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosisNeil C Henderson, Alison C Mackinnon, Sarah L Farnworth, et al.
Antimicrobial Resistance and Infection Control|September 7, 2021
Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort studyMelissa C MacKinnon, Scott A McEwen, David L Pearl, et al.
Pharmacology|February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Frontiers in Immunology|September 13, 2023
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1Joseph Mabbitt, Ian D Holyer, James A Roper, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
Galectin-3 regulates myofibroblast activation and hepatic fibrosisNeil C Henderson, Alison C Mackinnon, Sarah L Farnworth, et al.
Plos One|January 30, 2014
Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophagesYiannis N Kallis, Christopher J Scotton, Alison C Mackinnon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Journal of Clinical Pathology|November 4, 2010
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic diseaseAlexander C Mackinnon, Maria Tretiakova, Les Henderson, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptorsR D Clark, D B Repke, J Berger, et al.
Cancer Research|January 18, 2014
CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonistSana Sarvi, Alison C Mackinnon, Nicolaos Avlonitis, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
The American Journal of Pathology|January 19, 2008
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosisNeil C Henderson, Alison C Mackinnon, Sarah L Farnworth, et al.
Antimicrobial Resistance and Infection Control|September 7, 2021
Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort studyMelissa C MacKinnon, Scott A McEwen, David L Pearl, et al.
Pharmacology|February 3, 2025
Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D Herman, Ian Holyer, Duncan C Humphries, et al.
Frontiers in Immunology|September 13, 2023
Resistance to anti-PD-1/anti-PD-L1: galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1Joseph Mabbitt, Ian D Holyer, James A Roper, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
Galectin-3 regulates myofibroblast activation and hepatic fibrosisNeil C Henderson, Alison C Mackinnon, Sarah L Farnworth, et al.
Plos One|January 30, 2014
Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophagesYiannis N Kallis, Christopher J Scotton, Alison C Mackinnon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Journal of Clinical Pathology|November 4, 2010
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic diseaseAlexander C Mackinnon, Maria Tretiakova, Les Henderson, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-affinity relationships of 12-sulfonyl derivatives of 5,8,8a,9,10,11,12,12a,13,13a-decahydro-6H-isoquino[2,1-g][1 ,6] naphthyridines at alpha-adrenoceptorsR D Clark, D B Repke, J Berger, et al.
Cancer Research|January 18, 2014
CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonistSana Sarvi, Alison C Mackinnon, Nicolaos Avlonitis, et al.
Pageof 17